The FDA has approved Hovilpri for immunocompromised adults with refractory mucocutaneous HSV lesions, offering a novel oral treatment.

Simplex Castings Ltd concludes EGM regarding preferential equity and warrant issues. Final voting results to be announced by ...

The FDA has approved pritelivir to treat mucocutaneous lesions caused by herpes simplex virus in immunocompromised adult ...

The US FDA has approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) ...

A new PLOS Pathogens study shows that the interferon-induced GTPase GBP7 unexpectedly promotes HSV-1 infection by activating ...

UPMC Children’s Community Pediatrics is seeing a lot of viral upper respiratory infections and hand, foot and mouth. Penn ...

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- NVNM Chain today announced the launch of its Layer 1 testnet, opening an environment where institutions and developers can build and test applications that ...

The regulatory decision followed findings from PRIOH-1 Part C, an open-label, comparator-controlled Phase III superiority ...

Illicit crypto laundering hit $82B in 2025, per Chainalysis. How Reactor and KYT trace fund flows, what exchanges alert on, ...

Patrick Witt's exit leaves the White House crypto council with no named staff, a month after a 49-50 Senate cloture vote ...

More than 99 percent of international data flows through submarine telecommunications cables, according to ...

Maps the Epidermolysis Bullosa pipeline by development stage, therapy type and administration route, highlighting novel treatments, unmet needs and partnership activity.Dublin, Oct. (GLOBE NEWSWIRE) - ...